Table 8.
Pathogen | Vaccine Tradename ** | Route of Administration | Adjuvant | Manufacturer |
---|---|---|---|---|
Ebola Zaire Vaccine | ERVEBO® | Intramuscular | - | Merck & Co., Inc. Kenilworth, NJ, USA |
SARS-CoV-2 (Janssen COVID-19 Vaccine) * |
JNJ-78436735 | Intramuscular | - | Janssen Biotech Inc. Horsham, PA, USA |
* Vaccine based on Ad.26 and authorized for emergency use in the United States. ** The Oxford/AstraZeneca vaccine (trade name Vaxzevria®) was approved for emergency use by the World Health Organization, and in Europe but has not received FDA approval.